Free Access
Med Sci (Paris)
Volume 31, Number 8-9, Août–Septembre 2015
Page(s) 748 - 755
Section M/S Revues
Published online 04 September 2015
  1. Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol 2012 ; 33 : 579–589. [CrossRef] [PubMed] [Google Scholar]
  2. Battistini L, Piccio L, Rossi B, et al. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 2003 ; 101 : 4775–4782. [CrossRef] [PubMed] [Google Scholar]
  3. Na SY, Hermann A, Sanchez-Ruiz M, et al. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity 2012 ; 37 : 134–146. [CrossRef] [PubMed] [Google Scholar]
  4. Kooij G, Kroon J, Paul D, et al. P-glycoprotein regulates trafficking of CD8+ T cells to the brain parenchyma. Acta Neuropathol 2014 ; 127 : 699–711. [CrossRef] [PubMed] [Google Scholar]
  5. Compston A, Coles A. Multiple sclerosis. Lancet 2008 ; 372 : 1502–1517. [CrossRef] [PubMed] [Google Scholar]
  6. Crawford MP, Yan SX, Ortega SB, et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004 ; 103 : 4222–4231. [CrossRef] [PubMed] [Google Scholar]
  7. Jilek S, Schluep M, Rossetti AO, et al. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. Clin Immunol 2007 ; 123 : 105–113. [CrossRef] [PubMed] [Google Scholar]
  8. Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000 ; 192 : 393–404. [CrossRef] [PubMed] [Google Scholar]
  9. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002 ; 25 : 313–319. [CrossRef] [PubMed] [Google Scholar]
  10. Serafini B, Rosicarelli B, Magliozzi R, et al. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 2006 ; 65 : 124–141. [PubMed] [Google Scholar]
  11. Chevalier G, Suberbielle E, Monnet C, et al. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog 2011 ; 7 : e1002393. [CrossRef] [PubMed] [Google Scholar]
  12. Pignolet BS, Gebauer CM, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: a beneficial antitumor immune response going awry. Oncoimmunology 2013 ; 2 : e27384. [CrossRef] [PubMed] [Google Scholar]
  13. De Beukelaar JW, Verjans GM, van Norden Y, et al. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies. Cancer Immunol Immunother 2007 ; 56 : 1501–1506. [CrossRef] [PubMed] [Google Scholar]
  14. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012 ; 135 : 1622–1638. [CrossRef] [PubMed] [Google Scholar]
  15. Waki K, Yamada S, Ozawa Y, et al. A case of lymphocytic infundibuloneurohypophysitis: histophathological studies. Pituitary 1999 ; 1 : 285–290. [CrossRef] [PubMed] [Google Scholar]
  16. Scheikl T, Pignolet B, Dalard C, et al. Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus. J Immunol 2012 ; 188 : 4731–4735. [CrossRef] [PubMed] [Google Scholar]
  17. Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Ann Neurol 2002 ; 51 : 311–318. [CrossRef] [PubMed] [Google Scholar]
  18. Brien JD, Uhrlaub JL, Nikolich-Zugich J. Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection. Eur J Immunol 2007 ; 37 : 1855–1863. [CrossRef] [PubMed] [Google Scholar]
  19. Pinschewer DD, Schedensack M, Bergthaler A, et al. T cells can mediate viral clearance from ependyma but not from brain parenchyma in a major histocompatibility class I- and perforin-independent manner. Brain 2010 ; 133 : 1054–1066. [CrossRef] [PubMed] [Google Scholar]
  20. Brew BJ, Davies NW, Cinque P, et al. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 2010 ; 6 : 667–679. [CrossRef] [PubMed] [Google Scholar]
  21. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 2012 ; 366 : 1870–1880. [CrossRef] [PubMed] [Google Scholar]
  22. Du Pasquier RA, Kuroda MJ, Zheng Y, et al. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004 ; 127 : 1970–1978. [CrossRef] [PubMed] [Google Scholar]
  23. Martin-Blondel G, Delobel P, Blancher A, et al. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011 ; 134 : 928–946. [CrossRef] [PubMed] [Google Scholar]
  24. Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010 ; 10 : 251–261. [CrossRef] [PubMed] [Google Scholar]
  25. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011 ; 76 : 1697–1704. [CrossRef] [PubMed] [Google Scholar]
  26. Martin-Blondel G, Bauer J, Cuvinciuc V, et al. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection. Neurology 2013 ; 81 : 964–970. [CrossRef] [PubMed] [Google Scholar]
  27. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009 ; 73 : 1551–1558. [CrossRef] [PubMed] [Google Scholar]
  28. Antoniol C, Jilek S, Schluep M, et al. Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management? Neurology 2012 ; 79 : 2258–2264. [CrossRef] [PubMed] [Google Scholar]
  29. Martin-Blondel G, Alvarez M, Delobel P, et al. Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 2011 ; 82 : 691–693. [CrossRef] [PubMed] [Google Scholar]
  30. Gray F, Bazille C, Adle-Biassette H, et al. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005 ; 11 (suppl 3) : 16–22. [CrossRef] [Google Scholar]
  31. Polman CH, O’Connor PW, Havrdova E, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 ; 354 : 899–910. [CrossRef] [PubMed] [Google Scholar]
  32. Kappos L, Radue EW, O’Connor P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010 ; 362 : 387–401. [CrossRef] [PubMed] [Google Scholar]
  33. Giacomini PS, Rozenberg A, Metz I, et al. Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome. N Engl J Med 2014 ; 370 : 486–488. [CrossRef] [PubMed] [Google Scholar]
  34. Martin-Blondel G, Cuzin L, Delobel P, et al. Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? Aids 2009 ; 23 : 2545–2546. [CrossRef] [PubMed] [Google Scholar]
  35. Molon B, Gri G, Bettella M, et al. T cell costimulation by chemokine receptors. Nat Immunol 2005 ; 6 : 465–471. [CrossRef] [PubMed] [Google Scholar]
  36. Martin-Blondel G, Bauer J, Uro-Coste E, et al. Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8 T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome. Acta Neuropathol 2015 ; 129 : 463–465. [CrossRef] [PubMed] [Google Scholar]
  37. Chakrabarti LA, Lortholary O. L’IRIS : une réaction inflammatoire paradoxale chez les patients traités simultanément pour une tuberculose et une infection par le VIH. Med Sci (Paris) 2015 ; 31 : 53–59. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  38. Breton G. Syndrome inflammatoire de reconstitution immune. Med Sci (Paris) 2010 ; 26 : 281–289. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  39. Louapre C, Maillart E, Papeix C, Lubetzki C. Nouveautés thérapeutiques et stratégies émergentes dans la sclérose en plaques. Med Sci (Paris) 2013 ; 29 : 1105–1110. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Lanteri MC, Diamond MS, Norris PJ, Busch MP. Infection par le virus West Nile chez l’homme. II. Aspects physiopathologiques et réponses immunitaires. Med Sci (Paris) 2011 ; 27 : 382–386. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.